Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34+ selected graft

Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34⁺ selected graft

Bone Marrow Transplant. 2020 Aug;55(8):1632-1634. doi: 10.1038/s41409-019-0723-x. Epub 2019 Oct 23.

Richard J Lin¹, Matias Sanchez^{2

3}, Kamal Abbi^{2

4}, Sean M Devlin^{5

6}, Ann A Jakubowski^{2

6}, Esperanza B Papadopoulos^{2

6}, Juliet N Barker^{2

6}, Roni Tamari^{2

6}, James W Young^{2

6}, Boglarka Gyurkocza^{2

6}, Doris M Ponce^{2

6}, Parastoo B Dahi^{2

6}, Molly A Maloy², Sergio A Giralt^{2

6}, Miguel-Angel Perales^{2

6}, Hugo Castro-Malaspina^{2

6}

¹ Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. [email protected].
² Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Clinica Santa Maria, Santiago, Chile.
⁴ Green Bay Oncology, Appleton, WI, USA.
⁵ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁶ Weill Cornell Medical College, New York, NY, USA.

No abstract available